recombinant sema3a (R&D Systems)
Structured Review
Recombinant Sema3a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 49 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+sema3a+fc+chimera/Recombinant+Human+Semaphorin+3A+Fc+Chimera+Protein%2C+CF/us12384843-906-13-17
Average 93 stars, based on 49 article reviews
Images
Related Articles
Binding Assay:Article Title: Anti-semaphorin 3A antibodies Article Snippet: .. For the assessment of binding selectivity to Sema3A vs Sema3G, 1 nM Recombinant:Article Title: Anti-semaphorin 3A antibodies Article Snippet: .. For the assessment of binding selectivity to Sema3A vs Sema3G, 1 nM Article Title: Anti-semaphorin 3A antibodies Article Snippet: .. After 20 hours, the cells were treated for 1 hour with 10 nM Article Title: Hermes Regulates Axon Sorting in the Optic Tract by Post-Trancriptional Regulation of Neuropilin 1 Article Snippet: .. For Sema3A collapse assay, cultures were treated with either 450 ng/ml Article Title: Anti-semaphorin 3A antibodies Article Snippet: TABLE 9 EC50 values for phage display hits and recombination variants in the GCC assay Antibody EC50 (nM) TPP-15051 (Chiome) 243.40 TPP-15354 67.73 TPP-15355 >200 TPP-15356 >200 TPP-15357 50.73 TPP-15358 >200 TPP-15359 >200 TPP-15360 31.07 TPP-15361 >200 TPP-15362 >200 TPP-15363 >200 TPP-15364 >200 TPP-15365 142.87 TPP-15366 4.13 TPP-15367 170.87 TPP-15368 >200 TPP-15369 76.60 TPP-15370 4.33 TPP-15371 >200 TPP-15372 109.47 TPP-15373 >200 TPP-15374 8.13 TPP-15375 >200 TPP-15376 >200 TPP-15377 >200 TPP-15378 138.60 TPP-15379 >200 TPP-15380 135.40 TPP-15381 >200 TPP-15382 >200 TPP-15384 18.80 TPP-15385 6.00 TPP-15386 >200 TPP-15387 >200 TPP-15388 >200 TPP-15389 160.67 TPP-15390 >200 TPP-15391 >200 TPP-15392 >200 TPP-15393 >200 TPP-15394 >200 TPP-15395 66.47 TPP-15396 180.80 TPP-15397 >200 TPP-15398 12.00 TPP-15399 >200 TPP-15400 25.73 TPP-15401 >200 TPP17755 (Samsung) 52.67 TPP-23298 2.40 TPP-23334 2.24 TPP-23337 2.12 TPP-23374 2.19 The identified antibodies also show potencies in the single digit nanomolar range in the murine Growth Cone Collapse Assay, again considerably more potent than the tested prior art antibodies (two- to three-digit nanomolar potency), as shown in Table 9. .. Article Title: Compositions and methods for treating and preventing inflammation Article Snippet: Recombinant mouse CCL2/JE/MCP-1 (from E. coli) (R&D Systems) concentration used in vitro 100 ng/ml. .. Article Title: Compositions and methods for treating and preventing inflammation Article Snippet: Recombinant mouse CCL2/JE/MCP-1 (from E. coli) (R&D Systems) concentration used in vitro 100 ng/ml. .. Article Title: Compositions and methods for treating and preventing inflammation Article Snippet: Recombinant mouse CCL2/JE/MCP-1 (from E. coli) (R&D Systems) concentration used in vitro 100 ng/ml. .. Article Title: Anti-semaphorin 3A antibodies Article Snippet: .. After switching to serum-free culture medium, scratch wounds were created using the WoundMaker tool, after which the cells were treated with 1 nM Incubation:Article Title: Anti-semaphorin 3A antibodies Article Snippet: .. For the assessment of binding selectivity to Sema3A vs Sema3G, 1 nM Staining:Article Title: Anti-semaphorin 3A antibodies Article Snippet: .. After 20 hours, the cells were treated for 1 hour with 10 nM Concentration Assay:Article Title: Compositions and methods for treating and preventing inflammation Article Snippet: Recombinant mouse CCL2/JE/MCP-1 (from E. coli) (R&D Systems) concentration used in vitro 100 ng/ml. .. Article Title: Compositions and methods for treating and preventing inflammation Article Snippet: Recombinant mouse CCL2/JE/MCP-1 (from E. coli) (R&D Systems) concentration used in vitro 100 ng/ml. .. Article Title: Compositions and methods for treating and preventing inflammation Article Snippet: Recombinant mouse CCL2/JE/MCP-1 (from E. coli) (R&D Systems) concentration used in vitro 100 ng/ml. .. In Vitro:Article Title: Compositions and methods for treating and preventing inflammation Article Snippet: Recombinant mouse CCL2/JE/MCP-1 (from E. coli) (R&D Systems) concentration used in vitro 100 ng/ml. .. Article Title: Compositions and methods for treating and preventing inflammation Article Snippet: Recombinant mouse CCL2/JE/MCP-1 (from E. coli) (R&D Systems) concentration used in vitro 100 ng/ml. .. Article Title: Compositions and methods for treating and preventing inflammation Article Snippet: Recombinant mouse CCL2/JE/MCP-1 (from E. coli) (R&D Systems) concentration used in vitro 100 ng/ml. .. |
